Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2022-12-14 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第七届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution from the first meeting of the seventh Supervisory Board of the company. It details the meeting date, voting results, and election of the Supervisory Board Chairman. There is no financial data, no mention of annual or interim reports, no audit information, no earnings data, and no regulatory certifications. The content is about board/management decisions related to the Supervisory Board, which is part of the company's governance structure. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2022-12-14 Chinese
独立董事关于第七届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion regarding the appointment of senior management at the company's seventh board meeting. It references compliance with relevant laws and regulations and confirms the qualifications and appointment of specific senior executives. This type of document is related to board or management changes rather than a full annual report, audit report, or financial results. It is not a call transcript, earnings release, or regulatory filing of another type. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and focused on management appointments, confirming the classification.
2022-12-14 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations for the company 嘉事堂药业股份有限公司 (stock code 002462). It discusses the stock price movements over specific dates, confirms no undisclosed material information, and provides risk warnings to investors. There is no financial data, no detailed report, no management discussion, or earnings information. The document is a regulatory announcement about stock trading behavior and compliance with disclosure rules. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-12-05 Chinese
关于变更独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the change of an independent director at 嘉事堂药业股份有限公司. It details the appointment of a new independent director, the approval at a shareholders meeting, and compliance with regulatory requirements for board composition. There is no financial data, audit information, or report content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-11-29 Chinese
2022年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2022 first extraordinary general meeting of shareholders of the company 嘉事堂药业股份有限公司. It details the meeting date, attendance, voting results on proposals, and legal opinions confirming the validity of the meeting and resolutions. The document is short (1528 characters) and focuses on the voting results and meeting details rather than presenting financial data or a full report. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-11-29 Chinese
安理律师事务所关于嘉事堂药业股份有限公司2022年第一次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and resolutions of the 2022 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It details the legality and validity of the meeting, attendance, voting results, and compliance with relevant laws and company rules. The document is not a report of financial results, audit, or management discussion, but a legal opinion related to a shareholders meeting. It is not a simple announcement but a formal legal opinion letter. This fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it includes official voting results and legal validation of the shareholder meeting resolutions.
2022-11-29 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.